Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Oct 28;111(9):1718-25.
doi: 10.1038/bjc.2014.466. Epub 2014 Aug 21.

Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy

K S Courneya  1 , D C McKenzie  2 , J R Mackey  3 , K Gelmon  4 , C M Friedenreich  5 , Y Yasui  6 , R D Reid  7 , J R Vallerand  1 , S C Adams  1 , C Proulx  8 , L B Dolan  2 , E Wooding  9 , R J Segal  9
Affiliations
Randomized Controlled Trial

Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy

K S Courneya et al. Br J Cancer. .

Abstract

Background: The Combined Aerobic and Resistance Exercise Trial tested different types and doses of exercise in breast cancer patients receiving chemotherapy. Here, we explore potential moderators of the exercise training responses.

Methods: Breast cancer patients initiating chemotherapy (N=301) were randomly assigned to three times a week, supervised exercise of a standard dose of 25-30 min of aerobic exercise, a higher dose of 50-60 min of aerobic exercise, or a higher dose of 50-60 min of combined aerobic and resistance exercise. Outcomes were patient-reported symptoms and health-related fitness. Moderators were baseline demographic, exercise/fitness, and cancer variables.

Results: Body mass index moderated the effects of the exercise interventions on bodily pain (P for interaction=0.038), endocrine symptoms (P for interaction=0.029), taxane/neuropathy symptoms (P for interaction=0.013), aerobic fitness (P for interaction=0.041), muscular strength (P for interaction=0.007), and fat mass (P for interaction=0.005). In general, healthy weight patients responded better to the higher-dose exercise interventions than overweight/obese patients. Menopausal status, age, and baseline fitness moderated the effects on patient-reported symptoms. Premenopausal, younger, and fitter patients achieved greater benefits from the higher-dose exercise interventions.

Conclusions: Healthy weight, fitter, and premenopausal/younger breast cancer patients receiving chemotherapy are more likely to benefit from higher-dose exercise interventions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Body mass index as a moderator of exercise effects during breast cancer chemotherapy on (A) bodily pain, (B) endocrine symptoms, (C) taxane symptoms, (D) aerobic fitness, (E) muscular strength, and (F) fat mass. Note: positive change scores (or less negative change scores) are better for all outcomes except fat mass. Abbreviations: COMB=combined aerobic and resistance exercise; HIGH=high volume of aerobic exercise; STAN=standard volume of aerobic exercise.
Figure 2
Figure 2
Menopausal status as a moderator of exercise effects during breast cancer chemotherapy on (A) bodily pain, (B) endocrine symptoms, and (C) taxane symptoms; age as a moderator of exercise effects during breast cancer chemotherapy on (D) bodily pain and (E) taxane symptoms; and baseline aerobic fitness as a moderator of exercise effects during breast cancer chemotherapy on (F) endocrine symptoms and (G) taxane symptoms. Note: positive change scores (or less negative change scores) are better for all outcomes. Abbreviations: COMB=combined aerobic and resistance exercise; HIGH=high volume of aerobic exercise; STAN=standard volume of aerobic exercise.
See this image and copyright information in PMC

Comment in

References

    1. Alberga AS, Segal RJ, Reid RD, Scott CG, Sigal RJ, Khandwala F, Jaffey J, Wells GA, Kenny GP. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer. Support Care Cancer. 2012;20 (5:971–981. - PubMed
    1. Basen-Engquist K, Carmack C, Brown J, Jhingran A, Baum G, Song J, Scruggs S, Swartz MC, Cox MG, Lu KH. Response to an exercise intervention after endometrial cancer: differences between obese and non-obese survivors. Gynecol Oncol. 2014;133 (1:48–55. - PMC - PubMed
    1. Cella D, Peterman A, Hudgens S, Webster K, Socinski MA. Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane) Cancer. 2003;98 (4:822–831. - PubMed
    1. Church TS, Blair SN, Cocreham S, Johannsen N, Johnson W, Kramer K, Mikus CR, Myers V, Nauta M, Rodarte RQ, Sparks L, Thompson A, Earnest CP. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2010;304 (20:2253–2262. - PMC - PubMed
    1. Courneya KS. Physical activity and cancer survivorship: a simple framework for a complex field. Exerc Sport Sci Rev. 2014;42 (3:102–109. - PubMed

Publication types